FDA Drug Application (022011) for TYZEKA by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022011
Product Number001
FormTABLET;ORAL
Dosage600MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTYZEKA
Active IngredientTELBIVUDINE



Back to FDA Applications sponsored by NOVARTIS